Ceva Lung Program - Overview

The Ceva Lung Program (CLP) provides an overview of the diseases associated with Actinobacillus pleuropeumoniae, Mycoplasma hyopneumoniae and Aujeszky’s disease virus.

 

CEVA LUNG PROGRAM
- Overview -

By Dr Roman Krejci - Swine Corporate Technical Manager, CEVA Animal Health

 

 

The Ceva Lung Program (CLP) provides an overview of the diseases associated with Actinobacillus pleuropeumoniae, Mycoplasma hyopneumoniae and Aujeszky’s disease virus. It offers the methodology and guidelines on how to correctly evaluate the presence, incidence, circulation patterns and impact of these infections using serological investigation and adapted lung scoring of slaughter pigs.

The objective of CLP: is used to determine the appropriate vaccination protocol and monitor the results of vaccination with:

  • Hyogen® --> control Mycoplasma hyopneumoniae (M. hyo) – associated enzootic pneumonia
  • Coglapix® --> control Actinobacillus pleuropneumoniae (A.p.) - associated pleuro-pneumonia
  • Auphyl® Plus --> control Aujeszky’s diseasevirus (ADV) – associated intersticial pneumonia

 

...

 

--> Diseases

--> Making the Diagnosis

--> CLP scoring methodology (CLP- SM)

--> Vaccination strategies and Monitoring

--> Use of CLP

 

...

 .

<< Back to Ceva Lung Program

Back to top